Viewing StudyNCT02082977



Ignite Creation Date: 2024-05-06 @ 2:36 AM
Last Modification Date: 2024-10-26 @ 11:21 AM
Study NCT ID: NCT02082977
Status: TERMINATED
Last Update Posted: 2020-02-25
First Post: 2014-01-16

Brief Title: A Study to Investigate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With RelapsedRefractory Diffuse Large B Cell Lymphoma Transformed Follicular Lymphoma Other Non-Hodgkins Lymphomas Solid Tumors and Multiple Myeloma
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Cancer
Keywords:
Name View
Refractory View
Phase I study dose escalation study View
diffuse large B cell lymphoma View
Relapsed View
Solid tumors View
transformed follicular lymphoma View
Multiple myeloma View
GSK2816126 View
Non-Hodgkins lymphoma View